Rheumatology
Journal Abbreviation: RHEUMATOLOGY
ISSN: 1462-0324
eISSN: 1462-0332
Publisher: Oxford University Press
Publications (93)
New-onset versus relapsing giant cell arteritis treated with tocilizumab: 3-year results from a randomized controlled trial and extension (2021)
Stone JH, Spotswood H, Unizony SH, Aringer M, Blockmans D, Brouwer E, Cid MC, et al.
Journal article
Response to secukinumab on synovitis using Power Doppler ultrasound in psoriatic arthritis: 12-week results from a phase III study, ULTIMATE (2021)
D'Agostino MA, Schett G, Lopez-Rdz A, Senolt L, Fazekas K, Burgos-Vargas R, Maldonado-Cocco J, et al.
Journal article
Contrary immediate effect of abatacept on skin and joint manifestations in psoriatic arthritis (2021)
Valor-Méndez L, Kleyer A, Schett G, Manger B, Sticherling M
Journal article
Targeting of fibroblast activation protein in rheumatoid arthritis patients: imaging and ex vivo photodynamic therapy (2021)
Dorst DN, Rijpkema M, Buitinga M, Walgreen B, Helsen MMA, Brennan E, Klein C, et al.
Journal article
Resolution of vascular inflammation in patients with new-onset giant cell arteritis: data from the RIGA study (2021)
Schönau V, Roth J, Tascilar K, Corte G, Manger B, Rech J, Schmidt D, et al.
Journal article
Digital pitting scars are associated with a severe disease course and death in systemic sclerosis: a study from the EUSTAR cohort (2021)
Hughes M, Heal C, Henes J, Balbir-Gurman A, Distler J, Airo P, Mueller-Ladner U, et al.
Journal article
Long-term B-lymphocyte depletion and remission of granulomatosis with polyangiitis after two courses of rituximab treatment (2021)
Valor-Méndez L, Kleyer A, Rech J, Manger B, Schett G
Journal article
Herpes simplex infection in a patient with rheumatoid arthritis treated with baricitinib: a case report (2021)
Valor-Méndez L, Voskens C, Rech J, Kleyer A, Schett G
Journal article
Reactive arthritis and cutaneous vasculitis after SARS-CoV-2 infection (2021)
Schenker H, Hagen M, Simon D, Schett G, Manger B
Journal article
Resolution of enthesitis by guselkumab and relationships to disease burden: 1-year results of two phase 3 psoriatic arthritis studies. (2021)
Mcgonagle D, Mcinnes IB, Deodhar A, Schett G, Shawi M, Kafka S, Karyekar CS, et al.
Journal article